Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD Phase III trial adds a fourth class shown to benefit this population May 24, 2024
Ultraprocessed Food Consumption in Young Kids Tied to Cardiometabolic Risk Factors Link seen in adults for years, but study shows association in children ages 3 to 6 years May 23, 2024 video
New PAD Guidelines; AHA on Postpartum Care; Exercise Didn't Stop CAC Progression Recent developments of interest in cardiovascular medicine May 21, 2024
Four Might Be the Magic Number for Anticoagulation of Subclinical Afib ARTESiA trial analysis suggests a key threshold for CHA2DS2-VASc score May 20, 2024
Beta-Blocker Fails to Prevent COPD Exacerbations However, trial results don't affirm safety risks suggested by other studies May 20, 2024
Responders to PCI for Angina Relief Identified by Chest Pain Type Typical angina predicted PCI's efficacy in ORBITA-2 May 19, 2024
Mediterranean Diet After Afib Ablation: Maybe? Randomized trial fails to show benefit except in one group May 19, 2024
Ultra-Processed Foods and Mortality; Improving Cardiovascular Risk Assessment Also in TTHealthWatch: low testosterone in men and mortality May 18, 2024 podcast
Indian Myval Enters TAVR Horse Race With Good Early Performance Valve characterized by availability of intermediate sizes among other design features May 16, 2024
Teen Died From Eating Spicy Chip as Part of Social Media Challenge, Autopsy Says Cause of death was cardiopulmonary arrest, according to medical examiner's report May 16, 2024
Step-Down Antiplatelet Strategy Pairs Well With DCB Angioplasty REC-CAGEFREE II is the first randomized trial on antiplatelet strategies after DCB therapy May 15, 2024
Stacking Invasive Tests for Chronic Coronary Syndrome: Good Results, Less Hassle AID strategy boosted diagnostic yield upfront May 14, 2024
Balloon Pump Warning; Afib Rhythm Control vs Dementia; Doc's Sex Crime Charges Recent developments of interest in cardiovascular medicine May 14, 2024
Low Testosterone Linked With Mortality Risk in Aging Men Meta-analysis examined studies with mass spectroscopy measures, providing greater accuracy May 13, 2024
SGLT2i for Mitral Regurgitation; Mining Angiograms With AI; Melatonin and CVD Risk? Recent developments of interest in cardiovascular medicine May 07, 2024
Cardiologists Float Idea of Unionization Among Ways to Protect Employee Physicians Even senior physicians are being threatened, according to forum at SCAI May 05, 2024
Gene Therapy Allowing Heart to Grow New Blood Vessels Supported by Early Data Researchers are eyeing catheter-based delivery for people with refractory angina May 03, 2024
Devices Flop for Severe PAD; CPR on LVAD Patients; Cancer Drugs for Heart Disease? Recent developments of interest in cardiovascular medicine Apr 30, 2024
Dissolving Stent Approved for Peripheral Artery Disease Below the Knee The Esprit BTK everolimus-eluting scaffold is indicated for chronic limb-threatening ischemia Apr 29, 2024
Age-Related Somatic Mutations Implicated in Cardiovascular Death Clonal hematopoiesis a red flag for people with asymptomatic carotid atherosclerosis Apr 29, 2024
Consequences of Afib; Autism Heritability in Males and Females Also in TTHealthWatch: antipsychotics and dementia Apr 27, 2024 podcast
Does Ejection Fraction Make or Break Afib Ablation in Heart Failure Patients? Survival benefit does not extend to HFpEF group, meta-analysis suggests Apr 24, 2024
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids Data largely reassuring, but seizure finding requires further evaluation, experts say Apr 24, 2024
High BMI and Longevity; Infective Endocarditis in Young Whites; Damar Hamlin Update Recent developments of interest in cardiovascular medicine Apr 23, 2024
FDA Announces Recall of Heart Pumps Linked to Deaths and Injuries Recall comes years after issues were first raised Apr 21, 2024
Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says Topline results add yet another potential reason for use of dual GIP/GLP-1 receptor agonist Apr 18, 2024
Only One Harm From mRNA COVID Vaccines, Report Determines Independent reviewers reject causal links to infertility, myocardial infarction, stroke Apr 16, 2024
FDA Advisors' COIs; Ongoing Ukraine Heart Transplants; N.J. Cardiologist's $2M Fraud Recent developments of interest in cardiovascular medicine Apr 16, 2024
High Lipoprotein(a) Levels' Hit on Heart Health Doesn't Discriminate Atherogenic particle appeared to be a risk factor regardless of age, sex, race, diabetes status Apr 15, 2024
After Adverse Pregnancy Outcomes, Mortality Risk Lingers for Decades 40 years of data connect preterm birth, other gestational problems to multiple causes of death Apr 15, 2024
Cardiac Events Common in Older, Hospitalized RSV Patients New RSV vaccines could reduce risk, researchers said Apr 15, 2024
Persistent Non-HDL-C Dyslipidemia Starting in Childhood Tied to Higher CVD Risk But this was not the case for those with dyslipidemic levels that resolved by adulthood Apr 12, 2024
CDC: COVID Vax Not Linked to Sudden Deaths in Young Adults Mortality from vaccine-related myocarditis not supported by Oregon death records Apr 11, 2024
Novel Biannual Antihypertensive Shows Potential for Combination Therapy Drug might be most effective with a diuretic, according to suggestive data from a phase II trial Apr 09, 2024
Radial Cath Kits Recalled; siRNAs for Lipid Lowering; Smartphone HF Detection Recent developments of interest in cardiovascular medicine Apr 09, 2024
Third-Generation PCSK9 Inhibitor Cuts Cholesterol With Single, Small, Monthly Shot Patient acceptance could be an advantage, researchers say Apr 09, 2024
Early Win for Preemptive Stents on Vulnerable Coronary Plaque Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial Apr 08, 2024
Self-Selection for Statin Appears Safe, Effective Nonprescription rosuvastatin pans out in a second trial Apr 08, 2024
Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina After ORBITA-COSMIC, Reducer device's mechanism of benefit remains unknown Apr 08, 2024
Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial HDL therapeutic failed to reduce risk of MI, stroke, or cardiovascular death in high-risk group Apr 08, 2024
